Author:
Ghosh Arun K.,Chapsal Bruno D.
Funder
National Institutes of Health
Reference87 articles.
1. The most important references are indicated with an asterisk as∗
2. Global HIV/AIDS Response – Progress Report 2011;UNAIDS/WHO,2011
3. Anti-HIV Drugs: 25 Compounds Approved within 25 Years after the Discovery of HIV;De Clercq;Int. J. Antimicrob. Agents,2009
4. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection;Palella;New Engl. J. Med.,1998
5. AIDS – The First 20 Years;Sepkowitz;N. Engl. J. Med.,2001
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. FMO-guided design of darunavir analogs as HIV-1 protease inhibitors;Scientific Reports;2024-02-13
2. Design of substituted tetrahydrofuran derivatives for HIV-1 protease inhibitors: synthesis, biological evaluation, and X-ray structural studies;Organic & Biomolecular Chemistry;2024
3. Exploration of imatinib and nilotinib-derived templates as the P2-Ligand for HIV-1 protease inhibitors: Design, synthesis, protein X-ray structural studies, and biological evaluation;European Journal of Medicinal Chemistry;2023-07
4. Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2′ amide-derivatives: Synthesis, biological evaluation and structural studies;Bioorganic & Medicinal Chemistry Letters;2023-03
5. A convenient synthesis of (3S,3aR,5R,7aS,8S)-Hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-ol, a high-affinity nonpeptidyl ligand for highly potent HIV-1 protease inhibitors;Tetrahedron Letters;2022-10